Cargando…

Hypermethylated genes as biomarkers of breast cancer

Detalles Bibliográficos
Autores principales:	Fackler, MJ, Stearns, V, Khan, SA, Sukumar, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727103/ http://dx.doi.org/10.1186/1753-6561-3-S5-S19

Ejemplares similares

Relation of hormones in ductal lavage fluid to age, tamoxifen treatment, and breast cancer risk
por: Chatterton, RT, et al.
Publicado: (2009)

A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy
por: Stearns, V, et al.
Publicado: (2009)

Preoperative detection of multicentric breast cancer using tetrafosmin mammoscintigraphy
por: Varkey, S, et al.
Publicado: (2000)

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection
por: de Groot, Jolien S., et al.
Publicado: (2016)

Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer
por: Begam, Nasrin, et al.
Publicado: (2017)

Characterising breast tissue for the development of a tissue-equivalent phantom
por: Farquharson, MJ
Publicado: (2000)

Oncogenic viruses in nipple aspirate fluid: biomarkers for breast cancer risk assessment?
por: Baltzell, K, et al.
Publicado: (2009)

Role of the breast cancer susceptibility gene BRCA1 in radio-resistance
por: Sylvain, V, et al.
Publicado: (2000)

Using biomarkers to improve the diagnostic value of ductal fluid for early breast cancer detection
por: Haddad, B
Publicado: (2009)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Searching new biomarkers in nipple aspirate fluid: peroxidation status and adhesive molecules to early identify breast cancer
por: Mannello, F
Publicado: (2009)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Identification of breast cancer susceptibility genes using whole exome sequencing
por: Thompson, E, et al.
Publicado: (2012)

Constitutional alterations of the ATM gene in early-onset sporadic breast cancer
por: Maillet, P, et al.
Publicado: (2000)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Breast cancer and hormone replacement therapy (HRT): collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
por: Beral, V
Publicado: (2002)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer
por: Ingvarsson, S, et al.
Publicado: (2000)

Identification of two novel breast cancer associated genes by the differential display method
por: Maass, N, et al.
Publicado: (2000)

Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis
por: Cazzaniga, M, et al.
Publicado: (2009)

Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene BRCA2
por: Venkitaraman, A
Publicado: (2001)

The in vivo cell kinetics in breast carcinogenesis
por: Agnantis, NJ, et al.
Publicado: (2001)

Bioinformatic challenges for proteomic biomarkers of cancer
por: Tabb, David L, et al.
Publicado: (2011)

Personalised treatment for cancer: role of biomarkers
por: Duffy, Michael J
Publicado: (2014)

UK National Health Service Breast Screening Programme (NHSBSP) multicentre image guided biopsy trial: an update
por: Teh, W, et al.
Publicado: (2002)

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells
por: Zeillinger, R, et al.
Publicado: (2000)

Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice
por: Collins, NK, et al.
Publicado: (2000)

Constitutional methylation of cancer-related and selenoprotein coding genes in breast carcinoma in Polish population
por: Gupta, Satish, et al.
Publicado: (2012)

Treatment of breast cancer in elderly patients
por: Zappulla, E, et al.
Publicado: (2009)

Intraductal pegylated liposomal doxirubicin may achieve long term protection in HER2/NEU transgenic mice by restricting mammary gland outgrowth
por: Sukumar, S, et al.
Publicado: (2009)

Early exploration of two candidate breast cancer susceptibility genes identified by whole-exome sequencing
por: Blanc, R, et al.
Publicado: (2012)

Identification of new genes associated with breast and ovarian cancer risk. Advances of BCAC, CIMBA and OCAC
por: Jakubowska, A, et al.
Publicado: (2011)

Stages of screen-detected breast cancer
por: Koufopoulos, K, et al.
Publicado: (2000)

Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2021)

A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
por: Hartikainen, J, et al.
Publicado: (2000)

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer
por: Huzarski, T T, et al.
Publicado: (2012)

Breast cancer in elderly patients : the sentinel node biopsy
por: Minutolo, V, et al.
Publicado: (2010)

Local interferon-β gene therapy ameliorates adjuvant arthritis in rats
por: Adriaansen, P, et al.
Publicado: (2004)

Impact of BRCA1 mutation on survival after early onset breast cancer
por: Huzarski, T, et al.
Publicado: (2012)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hiab4pca7rupar6pd3udhql1ot